Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2026-04-28 Remuneration Information
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司董事及高级管理人员薪酬管理制度（2026年4月）
Remuneration Information Classification · 95% confidence The document is titled '董事及高级管理人员薪酬管理制度' which translates to 'Remuneration Management System for Directors and Senior Management' of 科美诊断技术股份有限公司. It details the principles, structure, assessment, and payment of remuneration for directors and senior management, including fixed and performance-based pay, incentives, and conditions for reduction or recovery of pay. It is a policy or system document about executive compensation rather than a report of actual compensation paid or a proxy statement. It does not contain financial results or voting information. Therefore, it fits the category of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2026-04-28 Chinese
科美诊断技术股份有限公司董事会审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the Board Audit Committee regarding the supervision of the external audit firm (Rongcheng CPA Firm) for the company's 2025 annual financial report audit. It details the audit firm's qualifications, audit procedures, communication with management, and the committee's oversight activities. The document does not contain the actual audited financial statements or the audit report itself but rather discusses the audit firm's performance and the committee's supervisory role. This fits the definition of an Audit Report / Information (AR) as it is a standalone report about the audit process and oversight, not the full annual report or the audit report itself. The document length is 1817 characters, which is relatively short but contains substantive content about audit supervision, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence.
2026-04-28 Chinese
科美诊断技术股份有限公司关于自愿披露公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a medical device registration certificate for a diagnostic product by a subsidiary. It details the product, its intended use, and the potential impact on the company. The document is short (1810 characters) and does not contain financial statements, earnings data, or detailed financial analysis. It is an official announcement about a regulatory approval rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous official announcements that do not fit other specific categories.
2026-04-19 Chinese
科美诊断技术股份有限公司2025年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2025年度业绩快报公告" which translates to "2025 Annual Performance Express Report Announcement" or "Earnings Quick Report." It contains preliminary financial data for the year 2025, including revenue, profit, and other key financial metrics. The data is explicitly stated as preliminary and unaudited, with a disclaimer that the final audited data will be in the formal annual report. The document is relatively short (1812 characters) and serves as an initial announcement of financial results rather than a full detailed report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. Therefore, the correct classification is ER with high confidence.
2026-02-27 Chinese
科美诊断技术股份有限公司2025年年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2025 annual performance forecast (业绩预告) issued by the company's board, providing preliminary profit estimates for the full fiscal year 2025. It includes expected net profit ranges, comparisons to the prior year, reasons for profit changes, and a risk warning. The document explicitly states that the forecast data is unaudited and preliminary, and the final audited data will be disclosed in the formal 2025 annual report. The document length is short (1238 characters) and it is a forward-looking earnings forecast rather than a full financial report or audited results. This type of document is best classified as an Earnings Release (ER), which covers initial announcements of periodic financial results or forecasts with key highlights only, not the full annual report (10-K) or audited report (AR).
2026-01-28 Chinese
科美诊断技术股份有限公司2025年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the '2025 Third Quarter Report' of 科美诊断技术股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data for the quarter and year-to-date, including income, profit, earnings per share, and balance sheet items. It explicitly states it is a quarterly report and includes unaudited financial statements. The length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2025-10-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.